Yu Akazawa

Years Active: 2018-2020
Publications (10 Years): 4

This page only lists publications with an associated author ORCID identifier.

Publications

Yu Akazawa, Yuki Saito, Toshiaki Yoshikawa, Keigo Saito, Kazuto Nosaka, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura
Efficacy of immunotherapy targeting the neoantigen derived from epidermal growth factor receptor T790M/C797S mutation in non-small cell lung cancer. Cancer science 111 (8) (2020)
Yu Akazawa, Ako Hosono, Toshiaki Yoshikawa, Hide Kaneda, Chika Nitani, Junichi Hara, Yoshiaki Kinoshita, Kenichi Kohashi, Atsushi Manabe, Miki Fukutani, Masashi Wakabayashi, Akihiro Sato, Kayoko Shoda, Manami Shimomura, Shoichi Mizuno, Yasunari Nakamoto, Tetsuya Nakatsura
Efficacy of the NCCV Cocktail-1 vaccine for refractory pediatric solid tumors: A phase I clinical trial. Cancer science 110 (12) (2019)
Yu Akazawa, Daisuke Nobuoka, Mari Takahashi, Toshiaki Yoshikawa, Manami Shimomura, Shoichi Mizuno, Toshiyoshi Fujiwara, Yasunari Nakamoto, Tetsuya Nakatsura
Higher human lymphocyte antigen class I expression in early-stage cancer cells leads to high sensitivity for cytotoxic T lymphocytes. Cancer science 110 (6) (2019)
Yu Akazawa, Masahiro Ohtani, Takuto Nosaka, Yasushi Saito, Kazuto Takahashi, Tatsushi Naito, Kazuya Ofuji, Hidetaka Matsuda, Katsushi Hiramatsu, Tomoyuki Nemoto, Yasunari Nakamoto
Long-term prognosis after biliary stenting for common bile duct stones in high-risk elderly patients. Journal of digestive diseases 19 (10) (2018)

Yu Akazawa.css-eqlu8i{font-size:small;padding-left:4px;}